Davis John E, Senior VP of Global Sales at Artivion Inc. (AORT), has been a consistent seller of company stock over the past two years, with no open-market purchases recorded in his 36 total Form 4 filings. His aggregate sell transactions total approximately $3.23 million, all in AORT shares, while his acquisition activity consists entirely of option exercises (code M) and compensation awards (code A) valued at zero. The most recent cluster of sales occurred in late February and early March 2026, with four open-market sales totaling roughly $494,500 between February 23 and March 3, alongside two zero-value grant awards on February 24 and March 2.
The selling pattern has been steady and recurring rather than concentrated. Notable single-day sales include $471,756 on August 12, 2025, $356,549 on March 11, 2025, and $300,966 on November 13, 2025. Several sales were paired with same-day option exercises—for instance, on November 17, 2025, he exercised options worth $189,390 and immediately sold shares valued at $288,817, a common pattern that suggests liquidity-driven dispositions rather than a directional bet against the stock. The largest single transaction in the dataset was the August 2025 sale, which coincided with an option exercise of $283,444.
Over the trailing twelve months, Davis has executed 17 open-market sales totaling roughly $2.6 million, with no purchases in that window. The absence of any code P transactions across his entire filing history indicates a purely one-sided sell bias, though the recurring option exercises and automatic tax-withholding events (code F, not present in this subset) complicate any simple narrative of conviction selling. His most recent activity—sales on March 2 and March 3, 2026, totaling $278,609—shows the pattern remains active into the current quarter.
AI-assisted summary